FDA is paving the way for new antibiotics to fill the empty pipeline, with initiatives by US and EC to cash incentivize Big Pharma. Better to have an open source RFP for the best ideas worldwide that to back one or two big slow horses.
http://lnkd.in/KiiBYc
linkedin post 2022-06-29 05:12:48
Nigel Fleming
September 21, 2022